What Sector Gamma AS reported holding on Form 13F for the quarter ended Sep 30, 2026.
CIK 1475373 · Filed Nov 12, 2026
Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR
| 1.3M |
| +26.2% |
| $36.1M |
| 7.5% |
MDTMedtronic plc | 381.2K | +8.2% | $32.9M | 6.8% |
MRKMerck & Co., Inc. | 193K | −11.0% | $28.1M | 5.8% |
INCYIncyte Corp | 155.1K | −9.2% | $18.8M | 3.9% |
BMRNBioMarin Pharmaceutical Inc | 293.3K | −0.6% | $17.6M | 3.6% |
CVSCVS Health Corp | 196.6K | +26.5% | $16.8M | 3.5% |
GEHCGE HealthCare Technologies Inc. | 256.9K | +23.6% | $16.8M | 3.5% |
ELVElevance Health, Inc. | 40.2K | −9.6% | $15.6M | 3.2% |
BIIBBiogen Inc. | 66.6K | +23.0% | $15.1M | 3.1% |
IONSIonis Pharmaceuticals Inc | 330K | +74.2% | $14.7M | 3% |
BRKRBruker Corp | 217.4K | +42.7% | $14.1M | 2.9% |
DHRDanaher Corp | 63.4K | New | $14M | 2.9% |
ABTAbbott Laboratories | 141.7K | −3.9% | $14M | 2.9% |
BDXBecton Dickinson & Co | 75.6K | −18.8% | $13.5M | 2.8% |
BSXBoston Scientific Corp | 308.1K | +154.4% | $13.4M | 2.8% |
BIOBio-Rad Laboratories, Inc. | 33.4K | ±0% | $12.6M | 2.6% |
ZBHZimmer Biomet Holdings, Inc. | 131.5K | −7.6% | $11.7M | 2.4% |
IQVIQVIA Holdings Inc. | 42.3K | −45.8% | $11.4M | 2.3% |
REGNRegeneron Pharmaceuticals, Inc. | 14.2K | −10.1% | $10.8M | 2.2% |
QGENQiagen N.V. | 231.2K | −19.6% | $10.1M | 2.1% |
LHLabcorp Holdings Inc. | 31K | +19.2% | $9.6M | 2% |
AVTRAvantor, Inc. | 606.1K | −33.1% | $9.1M | 1.9% |
CAHCardinal Health Inc | 40.3K | −1.0% | $9M | 1.8% |
CNCCentene Corp | 142.4K | −12.3% | $8.8M | 1.8% |
UNHUnitedHealth Group Inc | 20K | New | $7.3M | 1.5% |
AZNAstraZeneca PLC | 45K | New | $7.3M | 1.5% |
PTCTPTC Therapeutics, Inc. | 112K | +12.0% | $7.3M | 1.5% |
IOVAIovance Biotherapeutics, Inc. | 388.5K | −59.9% | $5.8M | 1.2% |
EWEdwards Lifesciences Corp | 60.4K | ±0% | $5.2M | 1.1% |
KURAKura Oncology, Inc. | 433K | ±0% | $4.6M | 1% |
SNDXSyndax Pharmaceuticals Inc | 241.7K | ±0% | $4.5M | 0.9% |
TNDMTandem Diabetes Care Inc | 267.1K | ±0% | $4.4M | 0.9% |
HCAHCA Healthcare, Inc. | 10K | New | $4.3M | 0.9% |
ASNDAscendis Pharma A/S | 18.3K | −14.1% | $4.2M | 0.9% |
TVTXTravere Therapeutics, Inc. | 68K | −15.0% | $4M | 0.8% |
MDGLMadrigal Pharmaceuticals, Inc. | 6.5K | New | $3.3M | 0.7% |
CYTKCytokinetics Inc | 45K | ±0% | $3M | 0.6% |
DNLIDenali Therapeutics Inc. | 137.7K | New | $2.8M | 0.6% |
ARDXArdelyx, Inc. | 686.8K | ±0% | $2.3M | 0.5% |
VRDNViridian Therapeutics, Inc.DE | 84.9K | New | $1.7M | 0.4% |